£4.5M
The New York and London based gifting software provider will use the capital to expand internationally and enhance support.
"Because of the pandemic, companies have lost their critical sales and marketing channels"
Funding Announcements
Filter
Filter & sort
The latest funding rounds from the UK tech ecosystem. Updated 4 November 2026.
Announcements
1,179
Total raised
£24.7B
disclosed amounts
This month
£9.0M
raised so far
£3.8M
Dubai blockchain investor O1ex backed the London neo bank in its latest round.
"India has tremendous potential in its fintech sector. We believe that the next big evolution in the Banking and Crypto space can actually happen from India. Hence, we have been actively working on developing products, working on our infrastructure, and recruitments to power our entry into the Indian market. Apart from India, we will also tap into the African and Caribbean market."
£7.5M
The London-based fintech secured £7.5m to scale its over-the-top buy now, pay later platform.
"Our unique over-the-top approach to BNPL has been built out of our strong knowledge for instalment cards in developing economies such as South Africa and South America amongst others. We combine the benefits of instalment and card products to offer the best way for our customers to pay overtime, anywhere. We believe that this generation should be able to responsibly have what they want, when they want without being financially penalised for the privilege."
£11.3M
The Series A round will fund international expansion and follows the confirmation of Brian Lesser as Executive Chairman.
"InfoSum is providing the industry with a decentralized marketing infrastructure that removes all privacy, identity and trust barriers, enabling seamless data connectivity across companies."
£3.4M
Maven Capital Partners co-led the £3.4m round to support the firm in scaling its operations overseas, notably in the US market.
"Gen inCode represents a fantastic opportunity for Maven to support a truly innovative business which is utilising AI and bioinformatics in order to enable medical practitioners to make more proactive, precise and impactful decisions on how they treat their patients. The precision medicine market is an exciting space and webelieve Gen inCode is well positioned to grow, leveraging its advanced genomic technology and the valuable IP it has amassed to date. We look forward to working with the senior management team to fulfil the company’s potential."
